Cloverleaf Bio
Developer of a Ribonucleic Acid (RNA) therapeutics development platform designed to revolutionize cancer therapy and patient outcomes in oncology. The company's platform allows for direct inhibition o...
Valuation
$0
Share Price
N/A
Total Raised
$1.1M
Last Round
N/A